RNA

Prosensa Holding N.V. Press Releases

$11.9
*  
0.01
0.08%
Get RNA Alerts
*Delayed - data as of Oct. 21, 2014 15:11 ET  -  Find a broker to begin trading RNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    RNA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Prosensa begins NDA submission to the FDA for exon-skipping drug drisapersen to treat Duchenne muscular dystrophy
10/10/2014 10:10:00 AM - GlobeNewswire


Prosensa extends the re-dosing of drisapersen in Europe in patients with Duchenne muscular dystrophy
9/26/2014 8:00:00 AM - GlobeNewswire


Prosensa to Present at Upcoming Conferences
9/25/2014 8:00:00 AM - GlobeNewswire


Prosensa publishes a sensitive, reproducible and objective methodology for dystrophin analysis in patients with Duchenne muscular dystrophy
9/24/2014 8:00:00 AM - GlobeNewswire


Prosensa announces commencement of re-dosing of drisapersen in North America in patients with Duchenne muscular dystrophy
9/17/2014 2:52:00 PM - GlobeNewswire


SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving Prosensa Holding N.V. and a Lead Plaintiff Deadline of September 16, 2014 -- RNA
9/10/2014 5:09:00 PM - GlobeNewswire


Prosensa announces 12 presentations at the 19th International Congress of the World Muscle Society in Berlin
9/9/2014 9:00:00 AM - GlobeNewswire


Deadline in Lawsuit for Investors in Prosensa Holding NV (RNA) Shares Announced by Shareholders Foundation
9/8/2014 10:00:00 AM - GlobeNewswire


Prosensa announces Lancet Neurology publication of an exploratory phase II study (DEMAND II) demonstrating efficacy and safety of drisapersen in patients with Duchenne muscular dystrophy
9/8/2014 8:00:00 AM - GlobeNewswire


Cure Duchenne Launches “Dollar 4 Duchenne” Campaign Today for World Duchenne Awareness Day
9/7/2014 8:00:00 AM - Business Wire


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Prosensa Holding N.V. (RNA) to Contact the Firm
9/5/2014 9:00:00 PM - Market Wire


Prosensa to Present at Upcoming Conferences
9/3/2014 8:51:00 AM - GlobeNewswire


SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Prosensa Holding N.V. and a Lead Plaintiff Deadline of September 16, 2014 -- RNA
8/25/2014 6:57:00 PM - GlobeNewswire


Prosensa Announces 2nd Quarter 2014 Financial Results and Recent Corporate Developments
8/12/2014 7:00:00 AM - GlobeNewswire


CureDuchenne Announces $7 Million (€5M) Collaboration with Prosensa to Help Speed Access to Treatments for Duchenne Muscular Dystrophy Patients
8/11/2014 4:05:00 PM - Business Wire


Prosensa and CureDuchenne Strengthen Long-term Collaboration with an Additional [Eur]5M to Advance DMD Pipeline
8/11/2014 4:00:00 PM - GlobeNewswire


Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014
8/11/2014 8:00:00 AM - Business Wire


Prosensa to Present at the Wedbush 2014 Life Sciences Conference
8/6/2014 8:00:00 AM - GlobeNewswire


Prosensa Holding N.V. to Webcast Conference Call Discussing 2nd Quarter 2014 Financial Results and Corporate Update on August 12, 2014
8/4/2014 8:00:00 AM - GlobeNewswire


PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Johnson & Weaver, LLP Reminds Investors of Upcoming September 16, 2014 Deadline; Encourages Investors with Significant Losses to Contact the Firm
7/26/2014 4:05:00 PM - Business Wire


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prosensa N.V. - RNA
7/25/2014 4:33:00 PM - PR Newswire